| scholarly article | Q13442814 |
| P50 | author | Rafael Fonseca | Q43059895 |
| David Cella | Q62568473 | ||
| P2093 | author name string | Lynne I Wagner | |
| Matthias Weiss | |||
| Don Robinson | |||
| Michael Katz | |||
| Phillip Greipp | |||
| P2860 | cites work | Multiple myeloma | Q24655964 |
| The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation | Q24807048 | ||
| Qualitative research in health care. Assessing quality in qualitative research | Q33807143 | ||
| Web surveys: a review of issues and approaches | Q34136791 | ||
| The Functional Assessment of Cancer Therapy scale: development and validation of the general measure | Q34361336 | ||
| Multiple myeloma: a review of the epidemiologic literature | Q36778871 | ||
| Individualizing treatment of patients with myeloma in the era of novel agents. | Q37143728 | ||
| Metaanalysis of the correlation between radiographic tumor response and patient-reported outcomes | Q40365317 | ||
| Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis. | Q51700947 | ||
| Pain, mood disturbance, and quality of life in patients with multiple myeloma. | Q53475914 | ||
| Evaluation of qualitative research studies | Q73307002 | ||
| Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation | Q79805988 | ||
| Clinically relevant end points and new drug approvals for myeloma | Q81527272 | ||
| Should symptoms be scaled for intensity, frequency, or both? | Q83083555 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1094-1104 | |
| P577 | publication date | 2012-05-09 | |
| P1433 | published in | Journal of Pain and Symptom Management | Q6295708 |
| P1476 | title | Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction | |
| P478 | volume | 43 |
| Q39665847 | Bone mineral density utilization in patients with newly diagnosed multiple myeloma |
| Q91949934 | Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care |
| Q50145894 | Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project |
| Q38791704 | Engaging Patients as Partners in Developing Patient-Reported Outcome Measures in Cancer-A Review of the Literature |
| Q64270406 | Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma |
| Q90593749 | Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry |
| Q30641981 | Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS) |
| Q58560605 | Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting |
| Q53838482 | Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study. |
| Q47100711 | Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods. |
| Q37567725 | Patient involvement in the development of patient-reported outcome measures: a scoping review. |
| Q37426566 | Quality of life and supportive care in multiple myeloma |
| Q30650394 | Review of health-related quality of life data in multiple myeloma patients treated with novel agents |
| Q37384918 | The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials |
| Q34485852 | Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life |
| Q28703564 | Validation of the M. D. Anderson Symptom Inventory multiple myeloma module |
| Q27316139 | Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma |
Search more.